Viking Therapeutics, Inc (VKTX)

Viking Therapeutics' VK2735 shows promise in obesity market, fueling acquisition speculation despite valuation concerns. Recent social media buzz highlights strong clinical data and competitive positioning against major players.

About Viking Therapeutics, Inc

Viking Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for metabolic and endocrine disorders.
Viking Therapeutics, Inc uses the ticker $VKTX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Viking Therapeutics, Inc (VKTX) trading volume is up 23.28% from the previous week.
Viking Therapeutics, Inc (VKTX) social dominance is up 225.92% from the previous week.
Viking Therapeutics, Inc (VKTX) Galaxy Score™ is up 26.09% from the previous week.
Viking Therapeutics, Inc (VKTX) creators is up 114.29% from the previous week.
Viking Therapeutics, Inc (VKTX) engagements is up 61.21% from the previous week.
Viking Therapeutics, Inc (VKTX) mentions is up 55.85% from the previous month.
Viking Therapeutics, Inc (VKTX) posts created is up 78.61% from the previous week.

Price: $29

Price 24-Hour Time-Series Raw Data
The current price is down due to recent negative price action and valuation concerns, compounded by the launch of Novo Nordisk's oral weight-loss pill and insider selling, despite positive sentiment from acquisition speculation and clinical data.

24-Hour: -5.6% 7-Day: 1.19% 30-Day: -14.5%

1-Year High: $42.10 on 2025-08-18
1-Year Low: $20 on 2025-04-08

AltRank: [--]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Viking Therapeutics, Inc (VKTX) is currently AltRank #86 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] [---]
[--] Month: [---] [---]
[--] Months: [---] +128
[--] Year: [---] [---]
1-Year High: [-----] on 2025-07-06
1-Year Low: [--] on 2025-02-22

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +12
[--] Month: [--] +7
[--] Months: [--] [---]
[--] Year: [--] +15
1-Year High: [--] on 2025-04-29
1-Year Low: [--] on 2025-02-25

Engagements: [-------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-------]
Daily Average: [-------]
[--] Week: [---------] +61%
[--] Month: [---------] -5.70%
[--] Months: [----------] -30%
[--] Year: [----------] -50%
1-Year High: [---------] on 2025-08-19
1-Year Low: [------] on 2025-12-28

Engagements by network (24h): X: [-------] TikTok: [--] Reddit: [--] YouTube: [---] News: [--]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [-----] +41%
[--] Month: [-----] +56%
[--] Months: [------] -25%
[--] Year: [------] -45%
1-Year High: [-----] on 2025-08-20
1-Year Low: [---] on 2025-12-21

Mentions by network (24h): X: [---] TikTok: [--] Reddit: [--] YouTube: [--] News: [--]

Creators: [---] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Viking Therapeutics, Inc (VKTX) in the last [--] hours which is down 13% from [---] in the previous [--] hours Daily Average: [---]
[--] Week: [---] +114%
[--] Month: [-----] +60%
[--] Months: [-----] -19%
[--] Year: [-----] +7.30%
1-Year High: [---] on 2025-08-20
1-Year Low: [--] on 2025-09-15

The most influential creators that mention Viking Therapeutics, Inc in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@danielnewmanUV	[--]	[-------]	[--]	[-----]
@TheValueTrade	[--]	[------]	[--]	[-----]
@JKeynesAlpha	[--]	[------]	[--]	[-----]
@WallStSai	[--]	[-----]	[--]	[-----]
@cloud_walker200	[--]	[---]	[--]	[-----]
@semodough	[--]	[-----]	[--]	[-----]
@MeadowCapital	[--]	[-----]	[--]	[-----]
@Alpha_bro1	[--]	[---]	[--]	[-----]
@Pharmdca	[--]	[-------]	[--]	[-----]
@Lab_Inversion	[--]	[-----]	[--]	[-----]

Sentiment: 78%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 78%
Daily Average: 74%
[--] Week: 71% -2%
[--] Month: 70% no change
[--] Months: 70% +13%
[--] Year: 70% +7%
1-Year High: 93% on 2025-04-26
1-Year Low: 53% on 2026-02-01

Most Supportive Themes:

Acquisition Speculation: (45%) Viking Therapeutics is being considered a potential acquisition target by larger pharmaceutical companies.
Positive Clinical Data and Market Growth: (30%) The company's obesity drug, VK2735, has shown promising Phase [--] data, contributing to optimism in the growing obesity treatment market.
Competitive Positioning: (15%) Viking Therapeutics is viewed as a strong competitor in the obesity market, with comparisons drawn to major players like Lilly and Novo Nordisk.

Most Critical Themes:

Valuation Concerns: (10%) Some market participants question Viking Therapeutics' current valuation, suggesting it may not fully justify a high buyout price based on Phase [--] data.

Social Dominance: 0.065%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.065%
Daily Average: 0.095%
[--] Week: 0.125% +0.086%
[--] Month: 0.141% +0.084%
[--] Months: 0.141% -0.11%
[--] Year: 0.141% -0.016%
1-Year High: 0.274% on 2025-08-20
1-Year Low: 0.03% on 2025-12-21

Market Dominance: 0.00383%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00383%
Daily Average: 0%
1-Year High: 0.127% on 2025-03-15
1-Year Low: 0.0032% on 2025-09-17

Market Cap: $3,379,963,129

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $3,379,963,129
Daily Average: $3,442,085,622
[--] Week: $3,379,963,129 +3.80%
[--] Month: $3,351,074,555 -13%
[--] Months: $3,351,074,555 +22%
[--] Year: $3,351,074,555 -1.50%
1-Year High: $4,732,808,408 on 2025-08-18
1-Year Low: $2,243,529,405 on 2025-04-08

Top Viking Therapeutics, Inc Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"@bioinvestor24 @cloud_walker200 $NVO will rationally pay much more for $VKTX than any other potential bidder. It's defensive for them. Not just expanding into a new market but protecting current revenues profit and share price"
X Link @Idomeneus_OG 2026-02-16T05:48Z [---] followers, [---] engagements

"@mikej36 @MeadowCapital The shorts have ruled this stock since the [----] $85 a share raise. The market priced in a Grand Slam Home run with the theme from the Natural playing for the Phase [--] Oral results. $VKTX hit a triple. Down it went. Now a competitor's bad news sinks $VKTX https://youtu.be/Y1pgp1BOqqMsi=HIcIkT-61h6QYhs0&t=319 https://youtu.be/Y1pgp1BOqqMsi=HIcIkT-61h6QYhs0&t=319"
X Link @Keith_Simonian 2026-02-16T05:19Z [---] followers, [---] engagements

"$VKTX $LLY $NVO When assessing the potential market value of #VK2735 keep in mind that during the MFN announcements we learned that there were agreements that Zepbound and Wegovy would be offered cash pay at $250 within [--] months. (Admittedly that could mean many things but the implication was all doses) Also of note at a closed press briefing with Lilly (I was personally on the call) Ricks stated that #retatrutide was not part of the negotiations. https://twitter.com/i/web/status/2023250670170657091 https://twitter.com/i/web/status/2023250670170657091"
X Link @ManOnThePen 2026-02-16T04:18Z [----] followers, [----] engagements

"Stock Watchlist: $DASH $COST $VKTX Started trading over [--] months ago and I lost $3K. Now I've made over $177K+ profits after joining their chat room and using their alerts. Discord Link Here:➡ https://discord.gg/vU3rnrCBhg https://discord.gg/vU3rnrCBhg"
X Link @Pro_Trader0000 2026-02-16T03:42Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing